TLR9 and type 1 diabetes mellitus: As observed in previous studies regarding the B cell phenotype (vide supra) [21], [22], the altered B cell homeostasis and TLR9-driven response that was reported in C/T T1D patients and in healthy controls emphasizes the potential effect of the variant prior to the clinical onset of autoimmunity in predisposed individuals.